Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | D(2) dopamine receptor | ||
Ligand | BDBM50443101 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1662860 (CHEMBL4012541) | ||
Ki | 0.690000±n/a nM | ||
Citation | Flick, AC; Ding, HX; Leverett, CA; Kyne, RE; Liu, KK; Fink, SJ; O'Donnell, CJ Synthetic Approaches to the New Drugs Approved During 2015. J Med Chem60:6480-6515 (2017) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
D(2) dopamine receptor | |||
Name: | D(2) dopamine receptor | ||
Synonyms: | D(2) dopamine receptor | DOPAMINE D2 | DOPAMINE D2 Long | DOPAMINE D2 Short | DRD2 | DRD2_HUMAN | Dopamine D2 receptor | Dopamine D2 receptor (D2) | Dopamine D2 receptor (D2R) | Dopamine D2A | Dopamine2-like | d2 | ||
Type: | Cell-surface receptors | ||
Mol. Mass.: | 50647.10 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P14416 | ||
Residue: | 443 | ||
Sequence: |
| ||
BDBM50443101 | |||
n/a | |||
Name | BDBM50443101 | ||
Synonyms: | Cariprazine | RGH-188 | ||
Type | Small organic molecule | ||
Emp. Form. | C21H32Cl2N4O | ||
Mol. Mass. | 427.411 | ||
SMILES | CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2cccc(Cl)c2Cl)CC1 |r,wU:6.5,wD:9.9,(-.77,5.69,;.57,4.92,;1.9,5.69,;.57,3.38,;-.77,2.61,;1.9,2.61,;1.9,1.07,;3.23,.3,;3.23,-1.24,;1.9,-2.01,;1.9,-3.55,;3.23,-4.32,;3.23,-5.86,;4.57,-6.63,;4.57,-8.17,;3.23,-8.94,;1.9,-8.17,;1.9,-6.63,;3.23,-10.48,;4.57,-11.25,;4.57,-12.79,;3.23,-13.56,;1.9,-12.79,;.57,-13.56,;1.9,-11.25,;.57,-10.48,;.57,-1.24,;.57,.3,)| | ||
Structure |